Eagle Pharmaceuticals Inc

General

Total Cases44

Active Cases8

Patents13

CourtsD. Delaware D. New Jersey E.D. North Carolina

TypeOperating Company

Elite Ratings

--

eagle-pharmaceuticals

eagle-pharmaceuticals

Ratings

Experience

Grade

Trend

DCT

L2

C

PTAB

--

--

--

CAFC

L2

C

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
09/09/24	Teva Pharmaceuticals Intl GmbH v. Bendarx 1:23-CV-00490 ( D. DE )	Pro Hac Vice Attorney April Barnard for BendaRx USA added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) (Entered: 09/09/2024)
09/06/24	Teva Pharmaceuticals Intl GmbH v. Bendarx 1:23-CV-00490 ( D. DE )	Pro Hac Vice Fee - Credit Card Payment received for April Barnard. ( re [79] MOTION for Pro Hac Vice Appearance of Attorney April Barnard )( Payment of $ 50, receipt number ADEDC-4492471).(Metzler, Sara) (Entered: 09/06/2024)
09/06/24	Teva Pharmaceuticals Intl GmbH v. Bendarx 1:23-CV-00490 ( D. DE )	MOTION for Pro Hac Vice Appearance of Attorney April Barnard - filed by BendaRx USA. (Metzler, Sara) (Entered: 09/06/2024)
09/06/24	Teva Pharmaceuticals Intl GmbH v. Bendarx 1:23-CV-00490 ( D. DE )	SO ORDERED, re [79] Motion for Pro Hac Vice Appearance of Attorney April Barnard filed by BendaRx USA. Ordered by Judge Jennifer L. Hall on 9/6/2024. (ceg) (Entered: 09/06/2024)
08/14/24	Teva Pharmaceuticals Intl GmbH v. Bendarx 1:23-CV-00490 ( D. DE )	NOTICE OF SERVICE of Plaintiff Eagle Pharmaceuticals, Inc.'s Responses and Objections to Defendant BendaRx USA Corp's Third Set of Request for the Production of Documents and Things (Nos. 84-87) filed by Eagle Pharmaceuticals, Inc..(Joyce, Alexandra) (Entered: 08/14/2024)
08/14/24	Teva Pharmaceuticals Intl GmbH v. Bendarx 1:23-CV-00490 ( D. DE )	NOTICE OF SERVICE of Plaintiff Teva Pharmaceuticals International GMBH And Cephalon, LLC's Objections and Responses to Defendant BendaRx USA Corp.'s Third Set of Requests for Production (Nos. 84-87) filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) (Entered: 08/14/2024)
07/19/24	Eagle Pharma Inc v. Apotex Inc 1:24-CV-00064 ( D. DE )	ANSWERING BRIEF in Opposition re 40 MOTION for Judgment on the Pleadings filed by Eagle Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 7/26/2024. (Silver, Daniel) (Entered: 07/19/2024)
07/18/24	Eagle Pharma Inc v. Apotex Inc 1:24-CV-00064 ( D. DE )	NOTICE OF SERVICE of (1) Plaintiff Eagle Pharmaceuticals, Inc.'s Responses and Objections to Defendants' First Set of Joint Interrogatories (Nos. 1-9) and (2) Plaintiff Eagle Pharmaceuticals, Inc.'s Responses and Objections to Defendants' First Set of Requests for Production (Nos. 1-50) filed by Eagle Pharmaceuticals, Inc..(Zare, Maliheh) (Entered: 07/18/2024)
07/17/24	Eagle Pharma Inc v. Apotex Inc 1:24-CV-00064 ( D. DE )	ORAL ORDER Setting Teleconference: The Court has reviewed the Joint Motion for Teleconference to Resolve Protective Order Disputes (C.A. No. 24-64, D.I. 57; C.A. No. 24-65, D.I. 44; C.A. No. 24-66, D.I. 44). A discovery dispute teleconference is scheduled for August 20, 2024 at 3:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than August 6, 2024, the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than August 13, 2024, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. Ordered by Judge Jennifer L. Hall on 7/17/2024. Associated Cases: 1:24-cv-00064-JLH, 1:24-cv-00065-JLH, 1:24-cv-00066-JLH(ceg) (Entered: 07/17/2024) ORAL ORDER Setting Teleconference: The Court has reviewed the Joint Motion for Teleconference to Resolve Protective Order Disputes (C.A. No. 24-64, D.I. 57; C.A. No. 24-65, D.I. 44; C.A. No. 24-66, D.I. 44). A discovery dispute teleconference is scheduled for August 20, 2024 at 3:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than August 6, 2024, the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than August 13, 2024, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. Ordered by Judge Jennifer L. Hall on 7/17/2024. Associated Cases: 1:24-cv-00064-JLH, 1:24-cv-00065-JLH, 1:24-cv-00066-JLH(ceg) (Entered: 07/17/2024)
07/15/24	Eagle Pharma Inc v. Apotex Inc 1:24-CV-00064 ( D. DE )	Joint MOTION for Teleconference to Resolve Protective Order Disputes - filed by Baxter Healthcare Corporation. (Rovner, Philip) (Entered: 07/15/2024)